Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients

NCT01576406 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
88
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer